• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

KA6:GR

0.054 EUR 0.001 1.89%

As of 03:08:10 ET on 07/28/2014.

Snapshot for Karo Bio AB (KA6)

Open: 0.079 Day's Range: 0.054 - 0.079 Volume: 0
Previous Close: 0.053 52wk Range: 0.001 - 0.181 1-Yr Rtn: +5,300.00%

Stock Chart for KA6

No chart data available.
  • KA6:GR 0.054
  • 1D
  • 1M
  • 1Y
0.053
Interactive KA6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KA6

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 11.5284
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 0.0430
Est. PEG Ratio -
Market Cap (M EUR) 36.52
Shares Outstanding (M) 676.26
30 Day Average Volume 767
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KA6

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KA6

Karo Bio AB operates a drug research and development company. The Company develops precision drugs to treat major diseases in the field of nuclear receptors. Karo Bio works within many therapeutic areas including men and women's health, cardiovascular diseases, metabolic disorders and dermatology.

Per BengtssonPresident/CEOHenrik PalmChief Financial Officer
Maria SjoebergVP/Chief Scientific OfficerMark FarmeryHead:Business Development
More Company Profile & Key Executives for KA6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil